The Prime objective of “North America Blood Glucose Monitoring Market” report is to provides an in-depth analysis of all market dynamics including drivers and restraints, and trends and opportunities. Important factors supporting growth across various is also provided. Using the industrial figures, the market finds growth figures between the forecast period from 2019 to 2024. In order to present an executive-level model of the market and its future perspectives, the report presents a clear segmentation based on different parameters. The factors that affect these segments are also discussed in detail in the report.
Request For Sample Copy of North America Blood Glucose Monitoring Market Report @ https://www.industryresearch.co/enquiry/request-sample/13999761
Top Key Players Are:
North America Blood Glucose Monitoring Market Report Covers the Top Regions:
United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, GCC, South Africa, Brazil, Argentina.
Scope of North America Blood Glucose Monitoring Market:
The North American blood glucose monitoring market has been segmented into glucometer devices, test strips, and lancets. The glucometer devices segment is further segmented into hospital use and home use. North America BGM report also covers the Continuous glucose monitoring market, and it is segmented into the receiver and sensor. In the report, North America is segmented into the United States, Canada, and Rest of North America.
Have Any Query, Ask Our Industry Experts @ https://www.industryresearch.co/enquiry/pre-order-enquiry/13999761
Key Market Trends: – The Blood Glucose Test Strips Revenue Consists of up to 83% Share in the Self-monitoring Blood Glucose Market
Type 1 diabetic patients should test their blood glucose at least three times a day, based on which the administered insulin dosages alter accordingly.
The test strip is a one-time use entity, and therefore, the volume of the test strip sold per year is high, as compared to the self-blood glucose meter.
The test strip market held 83.3% of the self-blood glucose monitoring market in 2018.
CGM proves to be an instrumental tool for patients relying on insulin pumps or multiple daily injections (MDI) therapy, as it helps in the improvement of glycemic balance without aggregating the danger for severe hypoglycemia.
The United States Leads the Blood Glucose Monitoring Market
In 2018, the United States held the largest share in the blood glucose monitoring market, due to the large patient pool and broader acceptance of advanced technologies. The Increase in the blood glucose monitoring market is due to the rise in diabetes population in all age groups.
The market value in the United States is expected to cross USD 11 billion by 2024. Diabetes-related complications are mostly due to poor glucose control.
In the United States, the BGM Market is expected to record an approximate CAGR of 13% till 2024. Glucometers are now portable and accurate to use.
Also, other factors, such as technological innovations and advances, give much convenience in measuring blood glucose levels. One such advancement is in monitoring the blood glucose levels established with continuous glucose monitoring devices.
- Market Dynamics – Drivers, Restraints, and Opportunities
- Market Segmentation – Types, Applications, Regions, and Technology
- Market Trends
- Competitive Landscape
- SWOT Analysis and Porter’s Five Forces Analysis
Purchase North America Blood Glucose Monitoring Market Report @ https://www.industryresearch.co/purchase/13999761
Price of Report: $ 4000 (SUL)
Detailed TOC of North America Blood Glucose Monitoring Market Research Report 2019 – 2024:
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 Market Segmentation
5.1 Self-Monitoring Blood Glucose Devices
5.1.1 By Component (Value and Volume, 2012 – 2024)
220.127.116.11 Glucometer Devices
18.104.22.168 Test Strips
5.1.2 By End User
22.214.171.124 Hospital (Value and Volume, 2012 – 2024)
126.96.36.199.1 Glucometer Devices
188.8.131.52.2 Test Strips
184.108.40.206 Personal (Value and Volume, 2012 – 2024)
220.127.116.11.1 Glucometer Devices
18.104.22.168.2 Test Strips
5.2 Continuous Blood Glucose Monitoring
5.2.1 By Component (Value and Volume, 2012 – 2024)
5.3.1 North America
22.214.171.124 United States (Value and Volume, 2012 – 2024)
126.96.36.199.1 Self-Monitoring Blood Glucose
188.8.131.52.1.1 By Component (Glucometer Device, Test strips, Lancets)
184.108.40.206.1.2 By End User (Hospital and Home)
220.127.116.11.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
18.104.22.168.2 Continuous Glucose Monitoring
22.214.171.124.2.1 By Component (Sensors and Receivers)
126.96.36.199.2.2 By Company (Dexcom, Abbott, Medtronics and Others)
188.8.131.52 Canada (Value and Volume, 2012 – 2024)
184.108.40.206.1 Self-Monitoring Blood Glucose
220.127.116.11.1.1 By Component (Glucometer Device, Test strips, Lancets)
18.104.22.168.1.2 By End User (Hospital and Home)
22.214.171.124.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
126.96.36.199.2 Continuous Glucose Monitoring
188.8.131.52.2.1 By Component (Sensors and Receivers)
184.108.40.206.2.2 By Company (Dexcom, Abbott, Medtronics and Others)
220.127.116.11 Rest of North America (Value and Volume, 2012 – 2024)
18.104.22.168.1 Self-Monitoring Blood Glucose
22.214.171.124.1.1 By Component (Glucometer Device, Test strips, Lancets)
126.96.36.199.1.2 By End User (Hospital and Home)
188.8.131.52.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
184.108.40.206.2 Continuous Glucose Monitoring
220.127.116.11.2.1 By Component (Sensors and Receivers)
18.104.22.168.2.2 By Company (Dexcom, Abbott, Medtronics and Others)
6 MARKET INDICATORS
6.1 Type-1 Diabetes Population (2012-2024)
6.2 Type-2 Diabetes Population (2012-2024)
7 COMPETITIVE LANDSCAPE
7.1 COMPANY PROFILES
7.1.1 Abbott Diabetes Care
7.1.3 Johnson & Johnson
7.1.7 Ascensia Diabetes Care
7.1.8 Agamatrix Inc.
7.1.9 Bionime Corporation
7.2 COMPANY SHARE ANALYSIS
7.2.2 Johnson & Johnson
7.2.3 Abbott Diabetes Care
8 MARKET OPPORTUNITES AND FUTURE TRENDS
About Industry Research:
Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.
Name: Ajay More
Organization: Industry Research
Phone: +44 20 3239 8187 / +14242530807
Email: [email protected]
Our latest Report: Clinical Trial Management Systems Market 2019 Industry Demand, Share, Global Trend, Industry News, Business Growth, Top Key Players Update, Business Statistics and Research Methodology by Forecast to 2024